Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 31, 2005Proceedings of the National Academy of Sciences

Attenuation of tobacco smoke-induced lung inflammation by treatment with a soluble epoxide hydrolase inhibitor

View Full Paper
Ask AI
Bookmark
Share

Authors

KSKevin R. SmithWoodbury UniversityKPKent E. PinkertonUniversity of California, DavisTWTakaho WatanabeFood and Drug Safety Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Smith et al. (2005) studied this question.

synapsesocial.com/papers/6a95bd28c1d9c412482bf124https://doi.org/10.1073/pnas.0409591102
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Structural and inflammatory changes in COPD: a comparison with asthma.1998 · 329 citations
  2. 2The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS2002 · 149 citations
  3. 3Sidestream Cigarette Smoke Generation and Exposure System for Environmental Tobacco Smoke Studies1994 · 174 citations
  4. 4Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure Regulation2000 · 341 citations